Surgical Site Infection Clinical Trial
Official title:
SMS-Based Follow-Ups to Improve Post-Discharge Surgical Outcomes
NCT number | NCT03161262 |
Other study ID # | IRB00094000 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 9, 2017 |
Est. completion date | March 1, 2019 |
Verified date | May 2019 |
Source | Emory University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine whether low-cost Short Message Service (SMS)-based
follow-up medication reminders and surveys for surgical site infection (SSI) reporting can
improve outcomes by increasing medication adherence and earlier detection and care of SSI.
This will be a prospective study involving enrollment of patients onto the Memora Health
platform, a web application developed for automating SMS content to patients. Post-operative
patients will be identified by providers and enrolled prior to discharge, after which they
will be followed for 3 months.
Primary endpoints include medication adherence and patient satisfaction with the text
messaging tool. Secondary endpoints include early detection of SSIs, patient satisfaction
with overall post-discharge care and health-related quality of life, and pertinent 30-day
readmissions.
Status | Completed |
Enrollment | 235 |
Est. completion date | March 1, 2019 |
Est. primary completion date | March 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient has a working cell phone that can send and receive SMS/Multimedia Messaging Service (MMS) over the next three months - Patient has a working cell phone with a camera - Being able to read and write fluently in English - All patients identified in the Electronic Medical Record (EMR) with International Classification of Diseases (ICD)-10 codes for patients who underwent procedures with external wounds and can be at risk of surgical site infection (SSI). Only patients falling under the categories of 'Major Diagnostic' and 'Major Therapeutic' will be considered. Exclusion Criteria: - Patient deceased prior to discharge - Patient transferred to another hospital - Patient has a terminal illness with less than 3-month expected survival - Vulnerable populations including patients who are in the middle of a pregnancy or prisoners |
Country | Name | City | State |
---|---|---|---|
United States | Grady Health System | Atlanta | Georgia |
Lead Sponsor | Collaborator |
---|---|
Emory University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Medication adherence assessed with patient responses to medication reminders | Overall patient response rates to SMS reminders will be used to assess medication compliance. Participants are asked to reply to the reminders when they have taken the dose of medication. | Month 3 | |
Primary | Medication adherence assessed by Adherence to Refills and Medications Survey (ARMS) | The Adherence to Refills and Medications Survey (ARMS-7) is a 7-item survey asking respondents about their medication-taking behavior and factors that contribute to medication compliance or non-compliance. Participants select a score for each question ranging from 1-4, where 1 represents 'None' and 4 represents 'All'. The scores are treated as a continuous measure, with total points being added up, with lower scores indicating high adherence and high scores indicating low adherence. | Month 3 | |
Primary | Participant Satisfaction | Patient satisfaction with the SMS tool will be assessed using a 7-item survey administered at the conclusion of the study. Participants will rate the message reminders on a scale from 1 (very poor) to 5 (very good): helpfulness, ease of use, ease of understanding, frequency of messages, quality of messages, likelihood of continuing to use message reminders, and willingness to recommend message reminders to a friend. | Month 1 through Month 3 | |
Secondary | Early detection of surgical site infection (SSI) | Participants will be allowed to intermittently provide pain scores and pictures of their surgical sites to help increase early detection of surgical site infection (SSI) post-discharge. The value of these images in early detection of SSIs will be measured through physician reporting of SSIs. | Month 3 | |
Secondary | Early intervention of surgical site infection (SSI) | Participants will be allowed to intermittently provide pain scores and pictures of their surgical sites to help increase early detection of surgical site infection (SSI) post-discharge. The number of incidents of early intervention for SSIs will be determined as a method of measuring early detection of SSIs. | Month 3 | |
Secondary | Care Transitions Measure (CTM-15) Score | Care Transitions Measure (CTM-15) is a 15-item survey asking respondents to indicate their degree of agreement with statements relating to the quality of care transition from being hospitalized to being discharged. Respondents select from: 1=Strongly Disagree, 2=Disagree, 3=Agree, 4=Strongly Agree. Missing responses and selections of "Don't Know/Don't Remember/Not Applicable" do not contribute to the total score. A mean score is obtained and higher scores indicate a better transition during hospital discharge. | Day 1, Month 3 | |
Secondary | Number of visits with provider | Responses to the question "In the last 3 months, how many times did you visit this provider to get care for yourself?" will be compared between study groups. | Day 1, Month 3 | |
Secondary | Number of appointments for routine care | Responses to the question "In the last 3 months, did you make any appointments for a check-up or routine care with this provider? (1 = yes, 2 = no)" will be compared between study groups. | Day 1, Month 3 | |
Secondary | Satisfaction with time spent by provider on care | Responses to the question "In the last 3 months, did the provider spend enough time on your care?" will be compared between study groups. Participants rate their satisfaction with the amount of time their provider spent on their care on a 5-point scale where 1 = strongly agree and 5 = strongly disagree. | Day 1, Month 3 | |
Secondary | Overall rating of provider | Responses to the question "Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?" will be compared between study groups. | Day 1, Month 3 | |
Secondary | 30-Day Readmission | Readmission to the hospital within 30 days of hospital discharge will be obtained through Electronic Health Records. Any hospital admissions will be analyzed to determine if they are related to the recent procedure. | Day 30 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04096885 -
The Inselspital Surgical Cohort Study
|
||
Terminated |
NCT03820648 -
Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT04067843 -
Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study
|
N/A | |
Terminated |
NCT04042077 -
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
|
Phase 3 | |
Completed |
NCT05841576 -
Anaesthetic Management Guided by COMET Measurements
|
N/A | |
Withdrawn |
NCT05338281 -
NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT
|
N/A | |
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT01697748 -
Prospective Study on Cesarean Wound Outcomes
|
N/A | |
Terminated |
NCT01789697 -
Text Message Study
|
N/A | |
Recruiting |
NCT05966961 -
Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
|
||
Recruiting |
NCT05077592 -
Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site Infections
|
Phase 4 | |
Recruiting |
NCT05502380 -
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
|
Phase 3 | |
Recruiting |
NCT05763602 -
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
|
Phase 4 | |
Recruiting |
NCT03221023 -
Intrawound Vancomycin Prophylaxis for Neural Stimulator
|
Phase 2/Phase 3 | |
Completed |
NCT03257202 -
Topical Treatment and Prevalence of P. Acnes
|
Phase 2 | |
Completed |
NCT06154720 -
Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
|
||
Not yet recruiting |
NCT06465901 -
A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI
|
N/A | |
Not yet recruiting |
NCT04820075 -
Efficacy of an Intervention to Improve the Preoperative Shower in Scheduled Surgery
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Not yet recruiting |
NCT04496180 -
Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy
|
N/A |